Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.48 USD | -4.41% | -4.49% | +118.25% |
05-07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
05-06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.25% | 598M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Canaccord Genuity Assumes Stoke Therapeutics at Buy With $24 Price Target